BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526-1547. [PMID: 33097308 DOI: 10.1016/j.jhep.2020.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Olivero M, Gagliardi D, Costamagna G, Velardo D, Magri F, Triulzi F, Conte G, Comi GP, Corti S, Meneri M. Newly Diagnosed Hepatic Encephalopathy Presenting as Non-convulsive Status Epilepticus: A Case Report and Literature Review. Front Neurol 2022;13:880068. [DOI: 10.3389/fneur.2022.880068] [Reference Citation Analysis]
2 Kreisel W, Lazaro A, Trebicka J, Grosse Perdekamp M, Schmitt-Graeff A, Deibert P. Cyclic GMP in Liver Cirrhosis-Role in Pathophysiology of Portal Hypertension and Therapeutic Implications. Int J Mol Sci 2021;22:10372. [PMID: 34638713 DOI: 10.3390/ijms221910372] [Reference Citation Analysis]
3 Sanchez-Meza F, Torre A, Castillo-Martinez L, Sanchez-Roman S, Morales-Buenrostro LE. Evaluation of cerebral dysfunction in patients with chronic kidney disease using neuropsychometric and neurophysiological tests. Ren Fail 2021;43:577-84. [PMID: 33757399 DOI: 10.1080/0886022X.2021.1901740] [Reference Citation Analysis]
4 Weng J, Han X, Zeng F, Zhang Y, Feng L, Cai L, Liang K, Liu S, Li S, Fu G, Zeng M, Gao Y. Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs. Theranostics 2021;11:7620-39. [PMID: 34335954 DOI: 10.7150/thno.58515] [Reference Citation Analysis]
5 Miwa T, Hanai T, Nishimura K, Maeda T, Ogiso Y, Imai K, Suetsugu A, Takai K, Shiraki M, Shimizu M. Handgrip strength stratifies the risk of covert and overt hepatic encephalopathy in patients with cirrhosis. JPEN J Parenter Enteral Nutr 2021. [PMID: 34287991 DOI: 10.1002/jpen.2222] [Reference Citation Analysis]
6 Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Liver cirrhosis. Lancet 2021;398:1359-76. [PMID: 34543610 DOI: 10.1016/S0140-6736(21)01374-X] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Kroupina K, Bémeur C, Rose CF. Amino acids, ammonia, and hepatic encephalopathy. Analytical Biochemistry 2022. [DOI: 10.1016/j.ab.2022.114696] [Reference Citation Analysis]
8 Rose CF, Jalan R. Judging the value of ammonia measurement on lactulose dosing: Apples and oranges? CanLivJ 2021;4:72-4. [DOI: 10.3138/canlivj-2020-0036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Teh KB, Loo JH, Tam YC, Wong YJ. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis. Dig Liver Dis 2021;53:817-23. [PMID: 34011479 DOI: 10.1016/j.dld.2021.04.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jalan R, Rose CF. Heretical thoughts into Hepatic Encephalopathy. Journal of Hepatology 2022. [DOI: 10.1016/j.jhep.2022.03.014] [Reference Citation Analysis]
11 Rose CF, Jalan R, Shawcross DL. Erroneous Ammonia Measurement is Not Synonymous With a Lack of Efficacy of Ammonia-Lowering Therapies in Hepatic Encephalopathy. Clin Gastroenterol Hepatol 2021;19:2456-7. [PMID: 33524596 DOI: 10.1016/j.cgh.2021.01.046] [Reference Citation Analysis]
12 Ochoa-Sanchez R, Tamnanloo F, Rose CF. Hepatic Encephalopathy: From Metabolic to Neurodegenerative. Neurochem Res 2021. [PMID: 34129161 DOI: 10.1007/s11064-021-03372-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang K, Lu Y, Zhao Z, Zhang C. Bioinformatics-Based Analysis of lncRNA-mRNA Interaction Network of Mild Hepatic Encephalopathy in Cirrhosis. Comput Math Methods Med 2021;2021:7777699. [PMID: 34938356 DOI: 10.1155/2021/7777699] [Reference Citation Analysis]
14 Pujol O, Mimendia I, Martin-Dominguez L, Amat C, Barro V. Simultaneous bilateral dual mobility total hip arthroplasty dislocation in a patient with hepatic encephalopathy: A case report. Int J Surg Case Rep 2021;80:105705. [PMID: 33662911 DOI: 10.1016/j.ijscr.2021.105705] [Reference Citation Analysis]
15 Rattanasupar A, Chang A, Akarapatima K, Chaojin T, Piratvisuth T. Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial. Indian J Gastroenterol 2021. [PMID: 34129159 DOI: 10.1007/s12664-021-01150-2] [Reference Citation Analysis]
16 Morega S, Cătălin B, Simionescu CE, Sapalidis K, Rogoveanu I. Cerebrolysin Prevents Brain Injury in a Mouse Model of Liver Damage. Brain Sciences 2021;11:1622. [DOI: 10.3390/brainsci11121622] [Reference Citation Analysis]
17 Seifert LL, Schindler P, Schoster M, Weller JF, Wilms C, Schmidt HH, Maschmeier M, Masthoff M, Köhler M, Heinzow H, Wildgruber M. Recurrence of Hepatic Encephalopathy after TIPS: Effective Prophylaxis with Combination of Lactulose and Rifaximin. J Clin Med 2021;10:4763. [PMID: 34682886 DOI: 10.3390/jcm10204763] [Reference Citation Analysis]
18 García-Martínez R, Diaz-Ruiz R, Poncela M. Management of Hepatic Encephalopathy Associated with Advanced Liver Disease. Clin Drug Investig 2022. [PMID: 35536537 DOI: 10.1007/s40261-022-01146-6] [Reference Citation Analysis]
19 Gairing SJ, Müller L, Kloeckner R, Galle PR, Labenz C. Review article: post-TIPSS hepatic encephalopathy-current knowledge and future perspectives. Aliment Pharmacol Ther 2022. [PMID: 35181894 DOI: 10.1111/apt.16825] [Reference Citation Analysis]
20 Rocco A, Sgamato C, Compare D, Coccoli P, Nardone OM, Nardone G. Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives. Front Cell Dev Biol 2021;9:748253. [PMID: 34900994 DOI: 10.3389/fcell.2021.748253] [Reference Citation Analysis]
21 Brusilow WSA. Saul Brusilow: Understanding and treating diseases of ammonia toxicity. Anal Biochem 2022;636:114478. [PMID: 34808107 DOI: 10.1016/j.ab.2021.114478] [Reference Citation Analysis]
22 Yukawa‐muto Y, Kamiya T, Fujii H, Mori H, Toyoda A, Sato I, Konishi Y, Hirayama A, Hara E, Fukuda S, Kawada N, Ohtani N. Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial species. Hepatology Communications. [DOI: 10.1002/hep4.1954] [Reference Citation Analysis]
23 Li Y, Liu H, Chen K, Wu X, Wu J, Yang Z, Yao L, Wen G, Zhang C, Chen X, Chen X, Tang D, Wang X, Liu J. Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy. Front Med (Lausanne) 2021;8:706407. [PMID: 34527681 DOI: 10.3389/fmed.2021.706407] [Reference Citation Analysis]
24 Di Cerbo A, Roncati L, Marini C, Carnevale G, Zavatti M, Avallone R, Corsi L. Possible Association Between DHEA and PKCε in Hepatic Encephalopathy Amelioration: A Pilot Study. Front Vet Sci 2021;8:695375. [PMID: 34651032 DOI: 10.3389/fvets.2021.695375] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Costa R, Montagnese S. The role of astrocytes in generating circadian rhythmicity in health and disease. J Neurochem 2021;157:42-52. [PMID: 33539604 DOI: 10.1111/jnc.15312] [Reference Citation Analysis]
26 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Reference Citation Analysis]
27 Espina S, Gonzalez-Irazabal Y, Sanz-Paris A, Lopez-Yus M, Garcia-Sobreviela MP, Del Moral-Bergos R, Garcia-Rodriguez B, Fuentes-Olmo J, Bernal-Monterde V, Arbones-Mainar JM. Amino Acid Profile in Malnourished Patients with Liver Cirrhosis and Its Modification with Oral Nutritional Supplements: Implications on Minimal Hepatic Encephalopathy. Nutrients 2021;13:3764. [PMID: 34836020 DOI: 10.3390/nu13113764] [Reference Citation Analysis]
28 Ibáñez-Samaniego L, Rapado-Castro M, Cabrero L, Navarrete C, García-Mulas S, Ahumada A, Marquez L, Pérez MD, Rincon D, Bañares R, Garcia-Martinez R. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study. Eur J Neurol 2021. [PMID: 34634159 DOI: 10.1111/ene.15138] [Reference Citation Analysis]
29 Alabsawy E, Shalimar, Sheikh MF, Ballester MP, Acharya SK, Agarwal B, Jalan R. Overt hepatic encephalopathy is an independent risk factor for de novo infection in cirrhotic patients with acute decompensation. Aliment Pharmacol Ther 2022. [PMID: 35106777 DOI: 10.1111/apt.16790] [Reference Citation Analysis]
30 Faccioli J, Nardelli S, Gioia S, Riggio O, Ridola L. Neurological and psychiatric effects of hepatitis C virus infection. World J Gastroenterol 2021; 27(29): 4846-4861 [PMID: 34447230 DOI: 10.3748/wjg.v27.i29.4846] [Reference Citation Analysis]
31 Kjærgaard K, Mikkelsen ACD, Wernberg CW, Grønkjær LL, Eriksen PL, Damholdt MF, Mookerjee RP, Vilstrup H, Lauridsen MM, Thomsen KL. Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease-Current Knowledge, Mechanisms and Perspectives. J Clin Med 2021;10:673. [PMID: 33572481 DOI: 10.3390/jcm10040673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 López-lazcano AI, López-pelayo H, Gual A, Lligoña A, Vilas-riotorto V, Caballeria E, Bruguera P, Pintor L. Factors Affecting Quality of Life in Liver Transplant Candidates: An Observational Study. Transplantology 2021;2:64-74. [DOI: 10.3390/transplantology2010007] [Reference Citation Analysis]
33 Is B, Bombassaro IZ, Tovo CV, de Mattos ÂZ, Ahlert M, Chiesa T, de Mattos AA. Albumin in the management of hepatic encephalopathy: A systematic review and meta-analysis. Ann Hepatol 2021;26:100541. [PMID: 34600143 DOI: 10.1016/j.aohep.2021.100541] [Reference Citation Analysis]
34 Moran S, López-Sánchez M, Milke-García MDP, Rodríguez-Leal G. Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. World J Gastroenterol 2021; 27(22): 3050-3063 [PMID: 34168407 DOI: 10.3748/wjg.v27.i22.3050] [Reference Citation Analysis]
35 Kalo E, Read S, Ahlenstiel G. Targeting Gut–Liver Axis for Treatment of Liver Fibrosis and Portal Hypertension. Livers 2021;1:147-79. [DOI: 10.3390/livers1030014] [Reference Citation Analysis]
36 Yang Y, Fu S, Cao B, Hao K, Li Y, Huang J, Shi W, Duan C, Bai X, Tang K, Yang S, He X, Lu L. Prediction of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt treatment: a cohort study. Hepatol Int 2021;15:730-40. [PMID: 33977364 DOI: 10.1007/s12072-021-10188-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Chandna S, Zarate ER, Gallegos-Orozco JF. Management of Decompensated Cirrhosis and Associated Syndromes. Surg Clin North Am 2022;102:117-37. [PMID: 34800381 DOI: 10.1016/j.suc.2021.09.005] [Reference Citation Analysis]
38 Kronsten VT, Shawcross DL. Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation? Anal Biochem 2021;:114437. [PMID: 34715068 DOI: 10.1016/j.ab.2021.114437] [Reference Citation Analysis]
39 Kaps L, Hildebrand K, Nagel M, Michel M, Kremer WM, Hilscher M, Galle PR, Schattenberg JM, Wörns M, Labenz C. Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2022. [DOI: 10.1016/j.clinre.2022.101873] [Reference Citation Analysis]
40 Pelle J, Castelli FA, Rudler M, Alioua I, Colsch B, Fenaille F, Junot C, Thabut D, Weiss N. Metabolomics in the understanding and management of hepatic encephalopathy. Anal Biochem 2022;636:114477. [PMID: 34808106 DOI: 10.1016/j.ab.2021.114477] [Reference Citation Analysis]
41 Barone M, Suppressa P, Viggiani MT, Lenato GM, Scardapane A, Chiumarulo L, Ambrosini N, Leo AD, Sabbà C. Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia. Eur J Intern Med 2021;90:43-8. [PMID: 34020869 DOI: 10.1016/j.ejim.2021.04.026] [Reference Citation Analysis]
42 Chu YY, Wang X, Dai HL. Update on pharmacotherapy of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2021; 29(2): 58-64 [DOI: 10.11569/wcjd.v29.i2.58] [Reference Citation Analysis]
43 Lauretani F, Longobucco Y, Maggio M. Gut microbiota and motoric-cognitive frailty in hospitalized older persons. Curr Opin Clin Nutr Metab Care 2021;24:209-15. [PMID: 33587364 DOI: 10.1097/MCO.0000000000000739] [Reference Citation Analysis]
44 Yin K, Wang D, Zhao H, Wang Y, Zhang Y, Liu Y, Li B, Xing M. Polystyrene microplastics up-regulates liver glutamine and glutamate synthesis and promotes autophagy-dependent ferroptosis and apoptosis in the cerebellum through the liver-brain axis. Environ Pollut 2022;:119449. [PMID: 35550135 DOI: 10.1016/j.envpol.2022.119449] [Reference Citation Analysis]